Keryx Biopharmaceuticals - Articles and news items

EC approves Fexeric for the treatment of hyperphosphatemia

Industry news / 24 September 2015 / Victoria White

Fexeric is approved for the control of elevated serum phosphorus levels in adults with chronic kidney disease, including both dialysis and pre-dialysis patients…

Keryx’s hyperphosphatemia treatment Fexeric backed for European approval

Industry news / 24 July 2015 / Victoria White

The CHMP has adopted a positive opinion for on marketing authorisation of Fexeric, recommending its approval for the treatment of hyperphosphatemia in CKD…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+